Apellis Pharmaceuticals, Inc. (BIT:1APLS)
20.21
+1.78 (9.67%)
At close: Dec 5, 2025
31.15% (1Y)
| Market Cap | 2.57B |
| Revenue (ttm) | 866.28M |
| Net Income (ttm) | 38.34M |
| Shares Out | n/a |
| EPS (ttm) | 0.31 |
| PE Ratio | 67.03 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | n/a |
| Previous Close | 18.43 |
| Day's Range | n/a |
| 52-Week Range | 14.60 - 25.89 |
| Beta | n/a |
| RSI | 59.66 |
| Earnings Date | Feb 25, 2026 |